A Class II recall covering 190 multidose vials distributed in Massachusetts gives the reason as lack of processing controls.
Silver Spring, Maryland, 13 August 2025 — The Food and Drug Administration enforcement file records an ongoing Class II recall initiated by Aequita Pharmacy of Kirkland, Washington, on 18 July 2025 and classified on 1 August 2025. The record covers 190 multidose vials of a compounded semaglutide and cyanocobalamin solution distributed in Massachusetts. Customers were notified by e-mail. The reason recorded is lack of processing controls.
Source documents
-
Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
- Identifier
- Recall number D-0563-2025
- As the record states
- Lack of Processing Controls.
- Recalling firm
- AEQUITA PHARMACY
- Firm location
- Kirkland, WA, United States
- Classification
- Class II
- Status on the record
- Ongoing
- Quantity
- 190 vials
- Distribution
- MA
- Initiated
- 2025-07-18
- Classified
- 2025-08-01